Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin

Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin

Two cases of autoimmune hemolytic anemia that occurred during the treatment of chronic hepatitis C with pegylated alpha-2a interferon and ribavirin, in HIV coinfected patients, are presented and described. The late occurrence (after six months of therapy) of this severe hemolytic anemia leads to the recommendation that hemoglobin levels should be monitored throughout the treatment period, even among patients who presented stable hemoglobin levels in the preceding months.

Saved in:
Bibliographic Details
Main Authors: Vilar,Fernando Crivelenti, Castro,Gleusa de, Moya,Maria Janete, Martinelli,Ana de Lourdes Candolo, Santis,Gil Cunha De, Cozac,Ana Paula Costa Nunes da Cunha, Figueiredo,José Fernando de Castro
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Medicina Tropical - SBMT 2007
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822007000600016
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822007000600016

Similar Items